Clinical trial
Safety and Efficacy of Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
NCT05604638 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
- Lead sponsor
- Second Affiliated Hospital of Guangxi Medical University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 24, 2024
- Completion date
- March 31, 2026
- Enrollment
- 348 (estimated)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke